02.06.2022 - BEIJING, June 02, 2022 (GLOBE NEWSWIRE) - Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer .